GD2-targeted multi-modular CAR-T

· University College London

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GD2-targeted multi-modular CAR-T, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma [Phase 1]